Novartis Makes New Data Integrity Commitment

Novartis Makes New Data Integrity Commitment

Source: 
RAPS.org
snippet: 

Looking to slow the fallout from Novartis’ data manipulation fiasco with its billion-dollar gene therapy Zolgensma (onasemnogene abeparvovec-xioi), CEO Vasant Narasimhan told an investor conference on Monday that the company will be more proactive in reporting data integrity issues to the US Food and Drug Administration (FDA).